Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Recently, the Indian Ministry of Health and Family Welfare issued a government ...
Granules Pharmaceuticals, a wholly owned subsidiary of Granules India, has rece...
The approval offers healthcare providers with an additional option alongside the...
The tender offer expired on 5 January 2026. The transaction involved purchasing ...
Sharp Sterile Manufacturing has announced a $28 million expansion of its site i...
Supriya Lifescience has built a strong global presence in Active Pharmaceutical...
The biologics sector is very dependent on single-use products and containment s...
1. Introduction: Usability Was Always There—MDR Just Started Asking th...
The condition has an estimated prevalence of 25,000 patients in the US and an an...
The approval applies to patients whose disease is metastatic or locally advanced...
Sigachi Industries, a leading global manufacturer of pharmaceutical excipients ...
The government is considering a separate licensing framework for bulk drugs, ac...
Dr. Reddy’s Laboratories announced the launch of Hevaxin, a novel recombinant v...
India’s healthcare and pharmaceutical industries stand at an inflection point. ...
The approval provides a new treatment option for this rare condition, which is l...
The first-in-class, subcutaneously administered hepcidin mimetic peptide, rusfer...
